ONCOassist Deployed in The Clatterbridge Cancer Centre as Enterprise System

Portable Medical Technology LtdPortable Medical Technology and The Clatterbridge Cancer Centre NHS Foundation Trust have announced an enterprise agreement which will see ONCOassist, Portable Medical Technology's revolutionary CE approved software system being deployed as the main oncology decision support system used within Clatterbridge.

ONCOassist was launched in January of last year following extensive development involving oncologists, system developers and compliance personnel in Europe and the United States. Since launch ONCOassist has garnered growing acceptance amongst oncology professionals throughout the UK and Ireland. In August of this year, the platform was offered as an enterprise system. This enables individual trusts and institutions to integrate their guidelines and protocols and make them available throughout the trust in an easy to access and intuitive format across multiple mobile operating systems including iOS, Android and Windows.

The Clatterbridge Cancer Centre, based in Wirral, Merseyside, have been working closely with the ONCOassist team over the past twelve months and an enterprise agreement was the logical next step. "After many discussions with Clatterbridge we realised that, as access to the most up to date version of their protocol library was so important, developing a guidelines and protocols engine that allows for the easy integration and updating of trust specific content that can interact with the many CE approved tools already present on the platform would be of huge benefit," said Eoin O’Carroll of ONCOassist.

Thomas Poulter, Head of IM&T at The Clatterbridge Cancer Centre, said: "Having ONCOassist available in clinics and on the wards will save our clinicians time. The oncology nurses and clinicians will have access to all of the key oncology decision support information and tools they need. For example, our nurses often need to reference protocols or treatment algorithms when delivering chemotherapy treatment. ONCOassist makes it easy to do this."

Jo Upton, Skin Cancer Advanced Nurse Practitioner at The Clatterbridge Cancer Centre, said: "A cancer nurse's role is continually evolving to meet the needs of our patients. Important decisions relating to the management of treatment side-effects and the patient experience of their treatment are fast becoming central to the cancer nurse's role, especially in the outpatient setting. It is essential that vital information to aid decision-making in practice is quick and easy to access. I have found that the ONCOassist app provides easy access to formulas and decision-support information in my day-to-day job."

Kevin Bambury of ONCOassist said: "We are delighted to have The Clatterbridge Cancer Centre as the first NHS trust using our enterprise system. We look forward to working with them over the coming years as we continue to add features and functionality to the system."

About Portable Medical Technology
Portable Medical Technology Ltd develops quality, accredited and trusted apps for medical specialists to reduce medical errors, improve efficiencies and progress patient communication. We combine the essential tools specialists need into a single, easy-to-use smartphone and table application that are FDA and CE approved and provide the latest updated tools to support critical medical decision-making.

Most Popular Now

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

Brain Imaging may Identify Patients Like…

By understanding differences in how people’s brains are wired, clinicians may be able to predict who would benefit from a self-guided anxiety care app, according to a new analysis from...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...

Stepping for Digital Rewards

Walking is well known to have significant health benefits, but few people achieve the daily recommended steps. Fortunately, mobile health (mHealth) applications have emerged as promising tools to promote physical...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...